Mch1r deficient mice
CA 2441708 A1 · Owner: Marsh, Donald J. · Inventors: Qian, Su; Marsh, Donald J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention features viable MCH1R deficient mice. MCH1R deficient mice contain an alteration in one or both MCH1R alleles that substantially reduces expression of a functional MCH1R from the altered allele. Preferably MCH1R deficient mice are MCH1R -/- knockout mice.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 19, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 19, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 19, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.